Hims & Hers Health fell -12% after guiding third-quarter adjusted EBITDA to $60m to $70m, below the $77m consensus. Second-quarter revenue missed expectations while adjusted earnings narrowly beat forecasts. The weaker outlook drove the selloff.
Join our Mailing list!
Sign up to get all the latest financial news and business updates.
Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.
